- July 16, 2021
- Posted by: Stratford Team
- Category: Business
Noubar Afeyan discusses the potential of a coronavirus booster shot on ‘The Claman Countdown’
Moderna, one of the leading COVID-19 vaccine providers, is set to join the S&P 500, the broadest measure of the U.S. stock market.
Shares jumped Friday adding to its annual gain of over 148%.
Ticker Security Last Change Change %MRNA MODERNA, INC. 283.11 +23.43 +9.02%
The inclusion may require mutual fund investors that mirror the benchmark to buy the stock which can often drive further gains.
RETAIL SALES SURGE AS ECONOMY GAINS MOMENTUM
The biotech company, which has already delivered over 100 million COVID-19 vaccines, will replace Alexion Pharmaceuticals Inc., which is being acquired by AstraZeneca on July 21 according to S&P Dow Jones Indices.
CLICK HERE TO READ MORE ON FOX BUSINESS
Ticker Security Last Change Change %ALXN ALEXION PHARMACEUTICALS, INC. 180.87 +0.36 +0.20%AZN ASTRAZENECA PLC 57.15 +0.19 +0.33%
Moderna is on track to deliver 1…